Oral care products and methods comprising AFPs
US-10507340-B2 · Dec 17, 2019 · US
US10898739B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10898739-B2 |
| Application number | US-201916715273-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 16, 2019 |
| Priority date | Oct 26, 2015 |
| Publication date | Jan 26, 2021 |
| Grant date | Jan 26, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are oral care compositions comprising antifreeze proteins (AFPs) useful in methods of repairing or inhibiting dental erosion, promoting dental remineralization, and/or enhancing the anti-cavity effects of fluoride.
Opening claim text (preview).
The invention claimed is: 1. A dentifrice comprising: a. an antifreeze protein (AFP), which has been neutralized to approximately neutral or slightly basic pH; b. an effective amount of fluoride and c. an orally acceptable carrier, wherein the AFP has the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a polypeptide sequence which arise from substitution, insertion or deletion of up to 5% of all amino acids, starting from the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, and which still has at least 50% of the biological property of the starting protein, and wherein the AFP is present in the dentifrice in an amount of from 0.01 weight % to 3 weight % by total weight of the dentifrice. 2. An oral care composition for use in repairing or inhibiting dental enamel erosion, promoting remineralization of dental enamel, and/or enhancing the anti-cavity effects of fluoride, said oral care composition comprising: a. an AFP; b. optionally an effective amount of fluoride; and c. an orally acceptable carrier, wherein the AFP has the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a polypeptide sequence which arise from substitution, insertion or deletion of up to 5% of all amino acids, starting from the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, and which still has at least 50% of the biological property of the starting protein, and wherein the AFP is present in the composition in an amount of from 0.01 weight % to 3 weight % by total weight of the composition. 3. The dentifrice of claim 1 wherein the AFP is coupled to a hydroxyapatite binding peptide which is selected from the group formed from SEQ ID NO:4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, and 19. 4. The dentifrice of claim 1 wherein the AFP is a homomer or heteromer of AFPs and coupled to a hydroxyapatite binding peptide which is selected from the group formed from SEQ ID NO:4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, and 19. 5. The dentifrice described in claim 1 wherein the dentifrice further comprises an effective amount of fluoride. 6. The dentifrice of claim 1 , wherein AFP has the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a polypeptide sequence which arise from substitution, insertion or deletion of up to 3% of all amino acids, starting from the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3 and which still has at least 80% of the biological property of the starting protein, and wherein AFP is present in the composition in an amount of from 0.01 weight % to 3 weight % by total weight of the dentifrice. 7. The dentifrice of claim 1 , wherein AFP has the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a polypeptide sequence which arise from substitution, insertion or deletion of up to 1% of all amino acids, starting from the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3 and which still has at least 90% of the biological property of the starting protein, and wherein AFP is present in the composition in an amount of from 0.01 weight % to 3 weight % by total weight of the dentifrice. 8. The dentifrice of claim 1 , wherein the AFP has the polypeptide sequence of SEQ ID NO: 1. 9. The dentifrice of claim 1 , wherein the AFP has the polypeptide sequence of SEQ ID NO: 2. 10. The dentifrice of claim 1 , wherein the AFP has the polypeptide sequence of SEQ ID NO: 3. 11. The oral care composition of claim 2 wherein the AFP is coupled to a hydroxyapatite binding peptide which is selected from the group formed from SEQ ID NO:4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, and 19. 12. The oral care composition of claim 2 wherein the AFP is a homomer or heteromer of AFPs and coupled to a hydroxyapatite binding peptide which is selected from the group formed from SEQ ID NO:4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, and 19. 13. The oral care composition described in claim 2 wherein the oral care composition further comprises an effective amount of fluoride. 14. The oral care composition of claim 2 , wherein AFP has the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a polypeptide sequence which arise from substitution, insertion or deletion of up to 3% of all amino acids, starting from the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3 and which still has at least 80% of the biological property of the starting protein, and wherein AFP is present in the composition in an amount of from 0.01 weight % to 3 weight % by total weight of the composition. 15. The oral care composition of claim 2 , wherein AFP has the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a polypeptide sequence which arise from substitution, insertion or deletion of up to 1% of all amino acids, starting from the polypeptide sequence as set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3 and which still has at least 90% of the biological property of the starting protein, and wherein AFP is present in the composition in an amount of from 0.01 weight % to 3 weight % by total weight of the composition. 16. The oral care composition of claim 2 , wherein the AFP has the polypeptide sequence of SEQ ID NO: 1. 17. The oral care composition of claim 2 , wherein the AFP has the polypeptide sequence of SEQ ID NO: 2. 18. The oral care composition of claim 2 , wherein the AFP has the polypeptide sequence of SEQ ID NO: 3.
Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title
Proteins; Peptides; Derivatives or degradation products thereof · CPC title
Fluorides; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.